Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study
Azahar, S.N.; Sulong, S.; Wan Zaidi, W.A.; Muhammad, N.; Kamisah, Y.; Masbah, N. Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study. Int. J. Environ. Res. Public Health 2022, 19, 1078. https://doi.org/10.3390/ijerph19031078
Azahar SN, Sulong S, Wan Zaidi WA, Muhammad N, Kamisah Y, Masbah N. Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study. International Journal of Environmental Research and Public Health. 2022; 19(3):1078. https://doi.org/10.3390/ijerph19031078
Chicago/Turabian StyleAzahar, Siti Norain, Saperi Sulong, Wan Asyraf Wan Zaidi, Norliza Muhammad, Yusof Kamisah, and Norliana Masbah. 2022. "Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study" International Journal of Environmental Research and Public Health 19, no. 3: 1078. https://doi.org/10.3390/ijerph19031078